H3B-6527
Iinkcukacha zeMveliso
Iithegi zeMveliso
Ubungakanani bePakethi | Ubukho | Ixabiso (USD) |
100mg | Ikhona evenkileni | 500 |
500mg | Ikhona evenkileni | 775 |
1g | Ikhona evenkileni | 1750 |
Iisayizi ezininzi | Fumana iiQuotes | Fumana iiQuotes |
Igama leMchiza:
N-(2-(((6-(3-(2,6-dichloro-3,5-dimethoxyphenyl))-1-methylureido)pyrimidin-4-yl)amino)-5-(4-ethylpiperazin-1-yl) phenyl)acrylamide
Ikhowudi yoncumo:
C=CC(NC1=CC(N2CCN(CC)CC2)=CC=C1NC3=NC=NC(N(C(NC4=C(Cl)C(OC)=CC(OC)=C4Cl)=O)C) =C3)=O
Ikhowudi ye-InChi:
InChI=1S/C29H34Cl2N8O4/c1-6-25(40)35-20-14-18(39-12-10-38(7-2)11-13-39)8-9-19(20)34- 23-16-24(33-17-32-23)37(3 )29(41)36-28-26(30)21(42-4)15-22(43-5)27(28)31/h6,8-9,14-17H,1,7,10-13H2 ,2-5H3,(H,35,40)(H,36,41)(H,32,33,34)
Isitshixo se-InChi:
MBWRLLRCTIYXDW-UHFFFAOYSA-N
Igama elingundoqo:
H3B-6527, H3B 6527, H3B6527, 1702259-66-2
Ukunyibilika:Inyibilika kwi-DMSO
Ugcino:0 - 4°C ixesha elifutshane (iintsuku ukuya kwiiveki), okanye -20°C ixesha elide (iinyanga).
Inkcazo:
I-H3B-6527 (i-H3 Biomedicine) yi-inhibitor ekhethiweyo kakhulu ye-FGFR4 kunye nomsebenzi onamandla we-antitumour kwi-FGF19 imigca yeseli ekhulisiwe kunye neegundane.
Ithagethi: FGFR4